Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 210826
Company: AUROBINDO PHARMA LTD
Company: AUROBINDO PHARMA LTD
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| LEVOMILNACIPRAN HYDROCHLORIDE | LEVOMILNACIPRAN HYDROCHLORIDE | EQ 20MG BASE | CAPSULE, EXTENDED RELEASE;ORAL | Discontinued | None | No | No |
| LEVOMILNACIPRAN HYDROCHLORIDE | LEVOMILNACIPRAN HYDROCHLORIDE | EQ 40MG BASE | CAPSULE, EXTENDED RELEASE;ORAL | Discontinued | None | No | No |
| LEVOMILNACIPRAN HYDROCHLORIDE | LEVOMILNACIPRAN HYDROCHLORIDE | EQ 80MG BASE | CAPSULE, EXTENDED RELEASE;ORAL | Discontinued | None | No | No |
| LEVOMILNACIPRAN HYDROCHLORIDE | LEVOMILNACIPRAN HYDROCHLORIDE | EQ 120MG BASE | CAPSULE, EXTENDED RELEASE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 01/06/2023 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |